![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, November 05, 2013 11:51:34 AM
1) The impending 3rd Quarter 2013 10Q Financial Report.
-- Total Revenues?
-- Total Net Profit?
-- Amounts, distribution, and origination of Revenues BY SITE and SOURCE.
In my post of Oct 6th, I rounded off all my predictions to the nearest 5k to reflect that the margin of error should be considered quite large, and hoped to do a more specific prediction later, after updating my revenue models to new historical data. However, I haven't had time to analyze the new data, so I'm just going to restate my original numbers, but this time rounded only to the nearest 1k:
Here's the breakdown for my Q3 predictions:
OL rev $ 429 k
OL returns $ 31 k
OL net $ 398 k (after returns)
WOL net 220 k (after returns)
Melrose 90 k (after returns)
Shipping 75 k
VivaVuva 4 k
---------------
Total rev 787 k (after returns)
As for profit, I think they'll be slightly profitable, around 20k in profit, but that's more of a guess than the revenue. It's based on the assumption that some one-time expenses from the previous quarter won't reappear, but there are also new costs compared to a year ago, due to the VivaVuva ramp-up.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM